Oracle Life Sciences Central Designer vulnerabilities

3 CVEs affecting Oracle Life Sciences Central Designer, 0 known to be exploited (CISA KEV), with EPSS scores. Latest: CVE-2026-21974, published 2026-01-20.

Highest priority

Known exploited (CISA KEV) first, then by EPSS exploit probability.

CVE-2026-21970, published 2026-01-20. Medium severity, CVSS 6.5. EPSS: 0.3% chance of exploitation in the next 30 days. Vulnerability in the Oracle Life Sciences Central Designer product of Oracle Health Sciences Applications (component: Platform). The supported version that is affected is 7.0.1.0. Easily…
CVE-2026-21923, published 2026-01-20. Medium severity, CVSS 6.5. EPSS: 0.3% chance of exploitation in the next 30 days. Vulnerability in the Oracle Life Sciences Central Designer product of Oracle Health Sciences Applications (component: Platform). The supported version that is affected is 7.0.1.0. Easily…
CVE-2026-21974, published 2026-01-20. Medium severity, CVSS 5.3. EPSS: 0.3% chance of exploitation in the next 30 days. Vulnerability in the Oracle Life Sciences Central Designer product of Oracle Health Sciences Applications (component: Platform). The supported version that is affected is 7.0.1.0. Easily…